Stocktoria
EssilorLuxottica Société anonyme EL.PA
FR · Euronext Paris · XPAR · stock · Healthcare · website
EssilorLuxottica Société anonyme financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €28.5B | €26.5B | €25.4B | €24.5B |
| Gross profit | €17.3B | €16.8B | €16.0B | €15.6B |
| R&D expense | €664.0M | €630.0M | €593.0M | €600.0M |
| SG&A expense | €13.0B | €12.5B | €12.1B | €11.7B |
| Operating income | €3.4B | €3.4B | €3.2B | €3.2B |
| Interest expense | €314.0M | €253.0M | €116.0M | €156.0M |
| Income tax | €752.0M | €800.0M | €609.0M | €751.0M |
| Net income | €2.3B | €2.4B | €2.3B | €2.2B |
| EPS (diluted) | €4.98 | €5.13 | €5.08 | €4.83 |
| Operating cash flow | €5.3B | €4.9B | €4.9B | €4.8B |
| Free cash flow | €3.8B | €3.4B | €3.3B | €3.2B |
| Cash & equivalents | €3.5B | €2.3B | €2.6B | €2.0B |
| Inventory | €3.5B | €3.2B | €2.8B | €2.8B |
| Goodwill | €31.0B | €32.1B | €30.3B | €30.7B |
| Total assets | €63.9B | €64.3B | €60.5B | €60.6B |
| Total debt | €14.4B | €13.2B | €11.7B | €12.2B |
| Total liabilities | €24.4B | €23.3B | €21.6B | €22.4B |
| Shareholders' equity | €38.9B | €40.4B | €38.2B | €37.5B |
| Share buybacks | €376.0M | €274.0M | €271.0M | €431.0M |
Growth · year-over-year · Revenue CAGR 5.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +7.5% | +4.4% | +3.7% | — |
| Net income growth | -1.9% | +3.1% | +6.4% | — |
| EPS growth | -2.9% | +1.0% | +5.2% | — |
| Free cash flow growth | +12.4% | +0.7% | +3.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · FR · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.